期刊文献+

博乐欣与阿米替林治疗门诊抑郁症患者对照研究 被引量:3

A comparative study of efficancy of venlafaxine and amitriptyline in the treatment of outpatients with depression
下载PDF
导出
摘要 目的比较博乐欣(文拉法辛)与阿米替林治疗门诊抑郁症的临床疗效和不良反应。方法对63例抑郁症患者随机分为两组,分别给予博乐欣和阿米替林治疗8周。采用汉密尔顿抑郁量表(HAMD)、药物不良反应量表(TESS)进行评临床疗效评定不良反应。结果博乐欣与阿米替林嗪显效率差异有显著性,博乐欣组显效快,不良反应少。结论博乐欣是一种安全有效的抗抑郁剂。 Objective To compare the efficacy and side-effects of domestic venlafaxine and amitriptyline in the treatment of outpatients with depression.Methods Sixty three patients with depression were randomly assigned into the treatment groups of domestic venlafaxine or amitriptyline for 8 weeks.HAMD was adopted to evaluate the curative effect.TESS were used to assess the side effects.Results Significant difference was found between the groups,and domestic venlafaxine took more quickly and its adverse events were less than amitriptyline.Conclusion Domestic venlafaxine is safe and efficient in the treatment of depression.
作者 梁丹 伍俊妍
出处 《中国现代药物应用》 2008年第1期53-54,共2页 Chinese Journal of Modern Drug Application
关键词 博乐欣(文拉法辛) 阿米替林 抑郁症 Venlafaxine Amitriptyline Depression
  • 相关文献

参考文献6

  • 1[1]Albert,D.Venlafaxine:Measuring the onset of antidepressant action.Psychopharmacol Bull,1995,31 (2):439-447.
  • 2[2]Vickl L.Venlafaxine:A heterocyclic antidepressant Am.J Hosp Pharm,1994,51:3036-3046.
  • 3[3]Montgomery SA,Entsuah R,Hackett D,et al.Venlafaxine versus placebo in the preventative treament of recurrent major depression.J Clin Psychiatry,2004,65:328-336.
  • 4[5]张继智,吉中孚.精神药物的合理应用.人民卫生出版社,2003:62-65.
  • 5窦桂忠 张爱珍.乐友治疗50例抑郁症的疗效观察[J].中华临床医学杂志,2006,12(1):28-28.
  • 6季建林,王祖承,舒良,周东丰,蔡焯基,马崔,肖计划,贾艳滨,王向群,李惠春,张心保,梅其一,丁宝坤.文拉法辛缓释剂治疗抑郁症急性期患者临床疗效的开放性研究[J].中华精神科杂志,2003,36(3):164-166. 被引量:29

二级参考文献13

  • 1田运华,王祖訢,顾牛范,施慎迅,黄明生,孙学礼,姚芳传,谢光荣,黄淑贞,秦英绂,许美庭.帕罗西汀与阿米替林治疗抑郁症的双盲对照研究[J].中华精神科杂志,1996,29(2):123-124. 被引量:4
  • 2施慎逊,张明园,陆峥,方贻儒,杨晓敏,盛尤荣,肖泽萍,田运华,秦英绂,黄淑珍,吉中孚,陈国强,许行建,张晋碚.氟西汀治疗抑郁症的多中心开放性对照研究[J].中华精神科杂志,1997,30(2):74-78. 被引量:45
  • 3Paykel E, Bamana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. Psycho Med,1995,25 : 1171-1180.
  • 4Thase ME, Entsuah AR, Rvdolph RL,et al. Remission rates during treatment with venlafaxine or SSRIs. Br J Psychiatry,2001,178:234-241.
  • 5Harvey AT, Rudolph RL, Preskorn SH. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry, 2000,57:503-509.
  • 6Feighner JP. Overview of antidepressants currently used to treat anxiety disorders. J Clin Psychiatry, 1999,60 Suppl 2:18-22.
  • 7Ballus C, Quiros G, De Flores T, et al. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive or dysthymia, Int Clin Psychopharmacol, 2000, 15: 43-48.
  • 8Mehetonen OP, Belinke K, Sogaard J,et al. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depression. J CAin Psychialry,2000, 61:95-100.
  • 9Poirer MF, Boyer P. Venlafaxine and paroxetine in treatment-resistant depression: double-blind, randomized comparison. Br J Psychiatry,1999, 175:12-16.
  • 10Costa E, Silva J. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression. J Clin Psychiatry, 1998,59:352-357.

共引文献30

同被引文献21

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部